APA (7th ed.) Citation

L, d. F., M, A., A, V., F, V., L, C., CJ, R., & A, G. (2025). Postvaccine early-onset (PoVEO) forms of Graves' disease after anti-SARS-CoV-2 vaccination are characterized by favourable long-term disease outcomes. Endocrine, 90(2), 467. https://doi.org/10.1007/s12020-025-04389-3

Chicago Style (17th ed.) Citation

L, di Filippo, Acanfora M, Vassallo A, Valsecchi F, Castellino L, Rosen CJ, and Giustina A. "Postvaccine Early-onset (PoVEO) Forms of Graves' Disease After Anti-SARS-CoV-2 Vaccination Are Characterized by Favourable Long-term Disease Outcomes." Endocrine 90, no. 2 (2025): 467. https://doi.org/10.1007/s12020-025-04389-3.

MLA (9th ed.) Citation

L, di Filippo, et al. "Postvaccine Early-onset (PoVEO) Forms of Graves' Disease After Anti-SARS-CoV-2 Vaccination Are Characterized by Favourable Long-term Disease Outcomes." Endocrine, vol. 90, no. 2, 2025, p. 467, https://doi.org/10.1007/s12020-025-04389-3.